 "Alembic Pharma dips 5% on disappointing September quarter results")
Shares of Alembic Pharmaceuticals dipped 5 per cent to Rs 757 on the BSE in the intra-day trade on Thursday after the company's consolidated profit declined 49 per cent year on year (YoY) at Rs 169 crore in September quarter (Q2FY22), due to lower revenue. The pharmaceutical company had posted profit of Rs 333 crore in the year-ago quarter.
At 10:45 am, the stock was trading 3.4 per cent lower at Rs 766.20, as compared to a 0.87 per cent decline in the S&P BSE Sensex. It had hit a 52-week low of Rs 720.80 on August 23, 2020.
At 10:45 am, the stock was trading 3.4 per cent lower at Rs 766.20, as compared to a 0.87 per cent decline in the S&P BSE Sensex. It had hit a 52-week low of Rs 720.80 on August 23, 2020.
